摘要
目的探讨吉诺通治疗呼吸道疾病的疗效。方法63例急性支气管炎、喘息性支气管炎(喘支)患儿随机分为两组,治疗组33例服用吉诺通胶囊,对照组30例服用羧甲司坦片,两组中感染病例加用β鄄内酰胺酶抗生素,喘支者加用盐酸丙卡特罗(治疗组用量减半)。结果治疗组在缓解咳喘症状的总有效率和显效率以及全身情况显著高于对照组(P<0.05),两组PEF%治疗前后无显著差异(P>0.05),各组自身治疗前后PEF%有显著差异(P<0.05)。结论吉诺通对呼吸道疾病有较高的治疗价值。
Objective: To explore the clinical efficacy of Gelomyrtol on respiratory diseases. Methods: 63 children with acute bronchitis and asthmatic bronchitis were randomly divided into treatment group with Gelomyrtol(33 cases) and control group with Carbocisteine (30 cases). Antibiotic was given in infectious cases, and meptin was given tothose of asthmatic bronchitis (half less in dosage for treatment group). Results: Both of the total effective rate and marked effective rate of the treatment group were significantly higher than that of control group in relieving respiratory symptoms (P < 0.05). PEF% of two groups was not obviously different before and after the treatment (P > 0.05), but the difference was obvious in each group themselves. (P < 0.05). Conclusion: Gelomyrtol has good efficacy for respiratory diseases and can be a primary choice.
出处
《儿科药学杂志》
CAS
2004年第5期36-37,共2页
Journal of Pediatric Pharmacy
关键词
吉诺通
儿童
呼吸道疾病
Gelomyrtol
Children
Respiratory diseases
